Techub News: MEI Pharma, Inc. (NASDAQ: MEIP) has acquired 929,548 LTC at an average price of $107.58, launching a significant institutional funding strategy in partnership with Charlie Lee and GSR Advising. As of August 4, LTC is currently valued at approximately $110.4 million. MEI has become the first publicly traded U.S. company to adopt Litecoin as a primary reserve asset, implementing a new strategy based on digital asset infrastructure and long-term capital innovation.